Page 118 - Genentech News Today

Ninety-four (94%) percent of global survey respondents working in healthcare agree that using data to drive healthcare creates new opportunities for patients...

– Enrollment continues globally in multiple clinical studies of vepdegestrant , including VERITAC-2 2L Phase 3 trial and study lead-in for the VERITAC-3 1L Phase 3 trial, both in ER+/HER2-...

The global artificial Intelligence (ai) in drug discovery market revenue is projected to surpass around USD 11,914 million by 2030 and is registering a...

“We knew it would really take a Crow woman to talk to other Crow women to get preventive health exams, and that’s how it started.”

Ottawa, Aug. 08, 2023 (GLOBE NEWSWIRE) -- The global artificial intelligence (ai) in drug discovery market revenue was valued at USD 1,495.28 million in 2022, a study published by Towards Healthcare a sister firm of

Biotech firm Genentech will pay more than $150,000 in fines to settle claims of alleged hazardous waste violations at its facility in South San Francisco.

Hospitals’ pharmacy spending is projected to rise by 3.42% next year, according to a new report. Specialty drugs, including Ozempic and Humira, as well as neurology medications are the primary drivers of this increase in pharmacy expenses.

/PRNewswire/ -- Duality Biologics (Suzhou) Co. Ltd. ("DualityBio"), a clinical-stage biotech company focusing on the discovery and development of next...

How to harness the potential of highly reactive radical molecules to work in pairs and spur transformative chemistry?Bulk them up.That is the approach of a new Cornell-led collaboration that attached large fragments to the infamously temperamental mo

/PRNewswire/ -- DelveInsights Bladder Cancer Market Insights report includes a comprehensive understanding of current treatment practices, bladder cancer...